HOLON, Israel, Nov. 3, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2021.

Sapiens International Corporation Logo

 

Summary Results for Third Quarter 2021 (USD in millions, except per share data)


GAAP


Non-GAAP



September 30, 2021

September 30, 2020

% Change

September 30, 2021

September 30, 2020

% Change

Revenue

$117.8

$97.6

20.7%

$118.4

$98.0

20.9%

Gross Profit

$48.3

$40.1

20.5%

$53.4

$44.2

20.8%

Gross Margin

41.0%

41.0%

-

45.1%

45.1%

-

Operating Income

$16.2

$12.1

34.1%

$21.0

$17.9

17.7%

Operating Margin

13.8%

12.4%

140 bps

17.7%

18.2%

(50) bps

Net Income (*)

$13.3

$9.3

42.1%

$17.0

$13.7

23.5%

Diluted EPS

$0.24

$0.18

33.3%

$0.31

$0.27

14.8%

(*) Attributable to Sapiens' shareholders

"Revenue in the third quarter increased by 21% year-over-year, reaching a non-GAAP quarterly record of $118.4 million, and non-GAAP operating profit increased to a record $21.0 million for an operating margin of 17.7%," stated Roni Al-Dor, President and CEO of Sapiens.

"We continue to reinforce Sapiens' leadership position in the evolving insurance software industry, across all tiers, both in P&C and Life & Annuities/Pension. We are landing new business and expanding by upselling and cross-selling to existing customers, while focusing on further advancing our product offerings and our commitment to customer success. The solid results we achieved in the third quarter were the direct outcome of successfully executing our strategy and our commitment to achieving consistent growth and improving operating margin," continued Mr. Al-Dor.

"We are reiterating our 2021 non-GAAP revenue guidance of $461 million to $466 million, expecting to reach approximately the midpoint of the range, and increasing our annual non-GAAP operating margin from 17.2%-17.5% to the range of 17.4%-17.5%," concluded Mr. Al-Dor.

Quarterly Results Conference Call
Management will host a conference call and webcast today, November 3, 2021 at 9:30 am. Eastern Time (3:30 pm. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-642-5032; International: +972-3-918-0609; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations. A replay of the call will be available one business day following the completion of the event, at the same link for 90 days.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative and agile. Backed by more than 35 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit www.sapiens.com or follow us on LinkedIn.

Media Contact

Shay Assaraf
Chief Marketing Officer, Sapiens
Shay.assaraf@sapiens.com

Investors Contact

Brett Maas
Managing Partner, Hayden IR
+1 646-536-7331
Brett.Maas@HaydenIR.com

Kimberly Rogers
Managing Director, Hayden IR
+1 541-904-5075
kim@HaydenIR.com

 

Forward Looking Statements

Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES                   

CONDENSED CONSOLIDATED STATEMENT OF INCOME                   
U.S. dollars in thousands (except per share amounts)




  Three months ended


  Nine months ended




 September 30


 September 30




2021


2020


2021


2020




 (unaudited)


 (unaudited)


 (unaudited)


 (unaudited)











 Revenue


117,812


97,645


341,810


281,242

 Cost of revenue


69,512


57,567


202,630


166,641











 Gross profit


48,300


40,078


139,180


114,601











 Operating expenses:










 Research and development, net


13,767


10,375


40,122


30,229


 Selling, marketing, general and administrative


18,316


17,606


57,302


49,594

 Total operating expenses


32,083


27,981


97,424


79,823











 Operating income


16,217


12,097


41,756


34,778











 Financial and other expenses (income), net


(72)


1,042


512


2,593

 Taxes on income


2,923


1,520


7,560


6,430





















 Net income


13,366


9,535


33,684


25,755











 Attributable to non-controlling interest


97


196


177


299











 Net income attributable to Sapiens' shareholders


13,269


9,339


33,507


25,456





















 Basic earnings per share


0.24


0.19


0.61


0.51











 Diluted earnings per share


0.24


0.18


0.60


0.50




















Weighted average number of shares outstanding used
to compute basic earnings per share (in thousands)


54,787


50,625


54,732


50,367










Weighted average number of shares outstanding used
to compute diluted earnings per share (in thousands)


55,611


51,581


55,564


51,280

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS
U.S. dollars in thousands (except per share amounts)



Three months ended


Nine months ended



September 30,


September 30,



2021


2020


2021


2020



(unaudited)


(unaudited)


(unaudited)


(unaudited)










GAAP revenue


117,812


97,645


341,810


281,242

Valuation adjustment on acquired deferred
revenue


630


323


1,889


323

Non-GAAP revenue


118,442


97,968


343,699


281,565










GAAP gross profit


48,300


40,078


139,180


114,601

Revenue adjustment


630


323


1,889


323

Amortization of capitalized software


1,920


1,600


5,595


4,627

Amortization of other intangible assets


2,563


2,205


7,697


6,346

Non-GAAP gross profit


53,413


44,206


154,361


125,897










GAAP operating income


16,217


12,097


41,756


34,778

Gross profit adjustments


5,113


4,128


15,181


11,296

Capitalization of software development


(2,064)


(1,506)


(5,655)


(4,194)

Amortization of other intangible assets


1,342


825


4,066


2,112

Stock-based compensation


657


1,361


3,527


2,747

Acquisition-related costs (*)


(246)


954


938


2,517

Non-GAAP operating income


21,019


17,859


59,813


49,256










  GAAP net income attributable to Sapiens'
  shareholders


13,269


9,339


33,507


25,456

  Operating income adjustments


4,802


5,762


18,057


14,478

  Tax effect on NON-GAAP adjustment


(1,095)


(1,355)


(3,707)


(2,436)

  Non-GAAP net income attributable to
  Sapiens' shareholders


16,976


13,746


47,857


37,498











(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

 

Adjusted EBITDA Calculation 
U.S. dollars in thousands



Three months ended


Nine months ended



September 30


September 30



2021


2020


2021


2020










GAAP operating profit


16,217


12,097


41,756


34,778










Non-GAAP adjustments:









Valuation adjustment on acquired deferred
revenue


 

630


323


 

1,889


323

Amortization of capitalized software


1,920


1,600


5,595


4,627

Amortization of other intangible assets


3,905


3,030


11,763


8,458

Capitalization of software development


(2,064)


(1,506)


(5,655)


(4,194)

Stock-based compensation


657


1,361


3,527


2,747

Compensation related to acquisition and
acquisition-related costs


(246)


954


938


2,517










Non-GAAP operating profit


21,019


17,859


59,813


49,256










Depreciation


1,125


1,151


3,371


3,332










Adjusted EBITDA


22,144


19,010


63,184


52,588

 

Summary of NON-GAAP Financial Information 
U.S. dollars in thousands (except per share amounts)


Q3 2021


Q2 2021


Q1 2021


Q4 2020


Q3 2020











Revenues

118,442


115,036


110,222


102,936


97,968

Gross profit

53,413


51,720


49,229


47,044


44,206

Operating income

21,019


19,795


19,000


18,666


17,859

Net income to Sapiens' shareholders

16,976


15,975


14,908


14,461


13,746

Adjusted EBITDA

22,144


20,920


20,120


20,032


19,010











Basic earnings per share

0.31


0.29


0.27


0.27


0.27

Diluted earnings per share

0.31


0.29


0.27


0.27


0.27

 

Non-GAAP Revenues by Geographic Breakdown 
U.S. dollars in thousands


Q3 2021


Q2 2021


Q1 2021


Q4 2020


Q3 2020











North America

48,952


46,767


44,754


47,303


49,979

Europe

59,707


59,718


57,642


49,225


42,394

Rest of the World

9,783


8,551


7,826


6,408


5,595











Total

118,442


115,036


110,222


102,936


97,968

 

Adjusted Free Cash-Flow
U.S. dollars in thousands


Q3 2021


Q2 2021


Q1 2021


Q4 2020


Q3 2020











Cash-flow from operating activities

14,556


26,845


11,755


21,030


16,705

Increase in capitalized software development costs

(2,064)


(1,959)


(1,632)


(1,604)


(1,506)

Capital expenditures

(1,082)


(1,082)


(821)


(725)


(963)

Free cash-flow

11,410


23,804


9,302


18,701


14,236











Cash payments attributed to acquisition-related
costs(*) (**)

477


-


1,280


2,363


242











Adjusted free cash-flow

11,887


23,804


10,582


21,064


14,478

(*) Included in cash-flow from operating activities
(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET
U.S. dollars in thousands




September 30,


December 31,




2021


2020




 (unaudited)


 (unaudited)







 ASSETS












 CURRENT ASSETS






Cash and cash equivalents


144,714


152,561


Short-term bank deposit


40,000


30,000


Trade receivables, net and unbilled receivables


76,031


65,409


Other receivables and prepaid expenses


14,670


19,388








Total current assets


275,415


267,358







 LONG-TERM ASSETS






Property and equipment, net


15,481


16,970


Severance pay fund


7,054


6,582


Goodwill and intangible assets, net


345,893


363,597


Operating lease right-of-use assets


48,356


54,390


Other long-term assets


7,685


5,264








Total long-term assets


424,469


446,803







 TOTAL ASSETS


699,884


714,161







LIABILITIES AND EQUITY











 CURRENT LIABILITIES






Trade payables


8,983


5,389


Current maturities of Series B Debentures


19,796


19,796


Accrued expenses and other liabilities


78,045


75,119


Current maturities of operating lease liabilities


10,973


9,924


Deferred revenue


33,634


34,548








Total current liabilities


151,431


144,776







 LONG-TERM LIABILITIES






Series B Debentures, net of current maturities


78,956


98,676


Deferred tax liabilities


12,925


16,010


Other long-term liabilities


12,772


12,129


Long-term operating lease liabilities


42,958


48,773


Redeemable non-controlling interest


97


517


Accrued severance pay


9,980


9,586








Total long-term liabilities


157,688


185,691







EQUITY



390,765


383,694







TOTAL LIABILITIES AND EQUITY


699,884


714,161

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands


For the nine months ended September 30,


2021


2020


(unaudited)


(unaudited)

 

Cash flows from operating activities:




Net income

33,684


25,755

Reconciliation of net income to net cash provided by operating activities:




Depreciation and amortization

20,729


16,417

Accretion of discount on Series B Debentures

76


91

Capital loss from sale of property and equipment

(60)


4

Stock-based compensation related to options issued to employees

3,527


2,747





Net changes in operating assets and liabilities, net of amount acquired:




Trade receivables, net and unbilled receivables

(14,673)


(10,225)

Deferred tax liabilities, net

(3,777)


(391)

Other operating assets

12,122


3,653

Trade payables

3,520


(778)

Other operating liabilities

(1,292)


(294)

Deferred revenues

(810)


(194)

Accrued severance pay, net

110


440





Net cash provided by operating activities

53,156


37,225





Cash flows from investing activities:




Purchase of property and equipment

(2,985)


(1,908)

Investment in deposits

(9,989)


(379)

Proceeds from sale of property and equipment

1,112


12

Proceeds from restricted deposit used for completed acquisition

-


22,890

Proceeds from (payments for) business acquisitions, net of cash acquired

831


(35,395)

Capitalized software development costs

(5,655)


(4,194)





Net cash used in investing activities

(16,686)


(18,974)





Cash flows from financing activities:




Proceeds from employee stock options exercised

1,028


4,919

Distribution of dividend

(20,255)


(7,044)

Repayment of Series B Debenture

(19,796)


(9,898)

Issuance of Series B Debentures, net of issuance expenses of $863

-


60,386

Receipt of short-term loan

-


20,000

Repayment of loan

-


(20,000)

Payment of contingent considerations

(926)


(538)

Acquisition of non-controlling interests

(990)


-

Dividend to non-controlling interest

(31)


-





Net cash provided by (used in) financing activities

(40,970)


47,825





Effect of exchange rate changes on cash and cash equivalents

(3,347)


(704)





Increase (decrease) in cash and cash equivalents

(7,847)


65,372

Cash and cash equivalents at the beginning of period

152,561


66,295





Cash and cash equivalents at the end of period

144,714


131,667

Debentures Covenants

As of September 30, 2021, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

Covenant 1 

  • Target shareholders' equity (excluding non-controlling interest): above $120 million.
  • Actual shareholders' equity (excluding non-controlling interest) equal to $389 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to (27.21)%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.00).

Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2021-financial-results-301415105.html

SOURCE Sapiens International Corporation

Copyright 2021 PR Newswire

Sapiens International Co... (NASDAQ:SPNS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Sapiens International Co... Charts.
Sapiens International Co... (NASDAQ:SPNS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Sapiens International Co... Charts.